Virologic Response Using Directly Observed Therapy in Adolescents With HIV: An Adherence Tool

Journal of the Association of Nurses in AIDS Care

Volumn 19, Issue 2, 2008, Pages 158-165

  Purdy, Julia Bilodeau ^a   Freeman, Alexandra F ^a   Martin, Staci C ^a   Ryder, Celia ^a   Elliott DeSorbo, Deborah K ^a   Zeichner, Steven ^a   Hazra, Rohan ^a  

^a NONE

Author keywords

adherence; adolescence; directly observed therapy; HIV AIDS; virologic response

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CHILD BEHAVIOR; CHILD PSYCHOLOGY; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION; DRUG MONITORING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; NURSING; NURSING ASSESSMENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; STATISTICS; VIROLOGY; VIRUS LOAD;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT PSYCHOLOGY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION, VERTICAL; DRUG MONITORING; FEMALE; HIV INFECTIONS; HUMANS; MALE; NURSING ASSESSMENT; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 40049110539     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2007.08.003     Document Type: Article

References (17)

1. Christie D., and Viner R. Adolescent development. British Medical Journal 330 (2005) 301-304
2. Deschamps A.E., Graeve V.D., van Wijngaerden E., DeSaar V., Vandamme A.M., van Vaerenbergh K., et al. Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care and STDs 18 (2004) 644-657
3. Glikman D., Walsh L., Valkenburg J., Mangat D., and Marcinak J.F. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications. Pediatrics 119 (2007) e1142-e1148
4. Gortmaker S.L., Hughes M., Cervia J., Brady M., Johnson G.M., Seage III G.R., et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New England Journal of Medicine 345 (2001) 1522-1528
5. Hazra R., Gafni R.I., Maldarelli F., Balis F.M., Tullio A.N., DeCarlo E., et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. Pediatrics 116 (2005) e846-e854
6. Levy R.W., Rayne C.R., Fairley C.K., Kong D.C., Mijch A., Costello K., et al. Multidisciplinary HIV adherence intervention: A randomized study. AIDS Patient Care and STDs 18 (2004) 728-735
7. Martin, S.C., Elliott, D.K., Toledo-Tamula, M.A., Wolters P.L., & Wood, L.V. (2004, April). Comparison of knowledge and perceptions of responsibility for medication adherence between HIV-positive children and their caregivers. Poster session presented at the annual meeting of the Society of Pediatric Psychology Meeting, Charleston, SC.
8. Matsui D.M. Drug compliance in pediatrics: Clinical and research issues. Pediatric Clinics of North America 44 (1997) 1-14
9. Murphy D.A., Belzer M., Durako S.J., Sarr M., Wilson C.M., and Muenz L.R. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Archives of Pediatrics and Adolescent Medicine 159 (2005) 764-770
10. Murphy D.A., Sarr M., Durako S.J., Moscicki A.B., Wilson C.M., and Muenz L.R. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Archives of Pediatrics and Adolescent Medicine 157 (2003) 249-255
11. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. New England Journal of Medicine 338 (1998) 853-860
12. Parsons G.N., Siberry G.K., Parsons J.K., Christensen J.R., Joyner J.L., Lee S.L., et al. Multidisciplinary, inpatient directly observed therapy for HIV-1 infected children and adolescents failing HAART: A retrospective study. AIDS Patient Care and STDs 20 (2006) 275-284
13. Roberts G.M., Wheeler J.G., Tucker N.C., Hackler C., Young K., Maples H.D., et al. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics 114 (2004) e346-e353
14. Van Dyke R.B., Lee S., Johnson G.M., Wiznia A., Mohan K., Stanley K., et al. Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 109 (2002) e61
15. Watson D.C., and Farley J.J. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatric Infectious Disease Journal 18 (1999) 682-689
16. Wiener L., Riekert K., Ryder C., and Wood L.V. Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible. AIDS Patient Care and STDs 18 (2004) 527-538
17. Yasuda J.M., Miller C., Currier J.S., Forthal D.N., Kemper C.A., Beall G.N., et al. The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antiviral Therapy 9 (2004) 743-761